|Slideshows|September 21, 2018

Sjögren Syndrome in Primary Care: A Quiz

Test your clinical acumen with this 5-question quiz.

Related Content

NEPTUNUS-1 and 2: Monthly Ianalumab Significantly Improves Sjögren Disease Activity

NEPTUNUS-1 and 2: Monthly Ianalumab Significantly Improves Sjögren Disease Activity

ByVictoria Johnson

November 4th 2025

Telitacicept Improves Sjögren Symptoms Over Placebo in Phase 3 Trial

Telitacicept Improves Sjögren Symptoms Over Placebo in Phase 3 Trial

ByVictoria Johnson

October 25th 2025

Cutaneous Vasculitis Subtype Associated With Poor Outcomes in Sjögren Disease

Cutaneous Vasculitis Subtype Associated With Poor Outcomes in Sjögren Disease

ByVictoria Johnson

August 13th 2025

Ianalumab Improves Sjögren Disease Activity in 2 Phase 3 Trials

Ianalumab Improves Sjögren Disease Activity in 2 Phase 3 Trials

ByVictoria Johnson

August 11th 2025

Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s

Ghaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s

ByVictoria Johnson

November 20th 2024